Infant HIV Type 1 gp120 Vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G Responses and Only Rare Envelope-Specific Immunoglobulin A Responses

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 27, 2014
Source ID
10.1093/infdis/jiu444

Entities

People

  • Barton Haynes
  • Brooke E. Liebl
  • Carrie Fry
  • Coleen K. Cunningham
  • David C. Montefiori
  • Elizabeth J. Mcfarland
  • Genevieve G. Fouda
  • Georgia D. Tomaras
  • Guido Ferrari
  • Hua-Xin Liao
  • Jaranit Kaewkungwal
  • Jerome H Kim
  • Justin Pollara
  • Kaylan Whitaker
  • Lin Ye Song
  • M Anthony Moody
  • Merlin L Robb
  • Nathan A. Vandergrift
  • Nelson Michael
  • Nicole L. Yates
  • Petronella Muresan
  • Punnee Pitisuttithum
  • R. Glenn Overman
  • Sallie R. Permar
  • Sorachai Nitayaphan
  • Supachai Rerks-ngarm
  • William Borkowsky
  • Xiaoying Shen

Organizations

  • Duke University
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Foundation for the National Institutes of Health
  • Frontier Science and Technology Research Foundation
  • Harvard T.H. Chan School of Public Health
  • Ministry of Public Health
  • National Center for Advancing Translational Sciences
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • New York University
  • United States Department of Defense
  • University of Colorado School of Medicine

Tags

Technology Areas

  • Biotechnology